🇺🇸 FDA
Patent

US 10155016

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

granted A61KA61K35/763A61K38/1748

Quick answer

US patent 10155016 (Compositions and methods for the treatment of wounds, disorders, and diseases of the skin) held by Krystal Biotech, Inc. expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Krystal Biotech, Inc.
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K35/763, A61K38/1748, A61K38/39, A61K47/38